| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2605 | Hsp90-in-s89 | Novel heat shock protein 90 (Hsp90), more potent enantiomer |
|
| DCC2606 | Htl0028016 | Novel macrocyclic calcitonin gene-related peptide (CGRP) receptor antagonist |
|
| DCC2607 | Htl0028125 | Novel macrocyclic calcitonin gene-related peptide (CGRP) receptor antagonist |
|
| DCC2608 | Htl26119 | Novel allosteric antagonist of the glucagon-like peptide-1 receptor (GLP-1R) |
|
| DCC2609 | Htl6641 | Novel, potent, selective, and orally efficacious dual antagonist of the orexin receptors |
|
| DCC2610 | hts05737 | Novel activator of PC2 |
|
| DCC2611 | Huhs029 | Novel analgesic agent, activating TRPA1 and subsequently desensitizing the channel, exhibiting higher inhibitory activity than resveratrol |
|
| DCC2612 | Human Vitronectin (351-359) | Adhesive peptide (sequence 351-359 mapped on the Human Vitronectin Protein), covalent and selective functionalizing on glass and titanium surfaces, increasng osteoblast attachment and adhesion strength and to promoting osseointegration |
|
| DCC2613 | Hur-ligand-4 | Novel human antigen R (HuR) ligand, acting as a HuR-RNA interferer |
|
| DCC2614 | Hy1-pt | Novel CK2-Specific Pt(II) Compound, Reversing Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments |
|
| DCC2615 | Hycanthone Mesylate | Inhibitor of apurinic endonuclease-1 (APE1) by direct protein binding |
|
| DCC2616 | Hydro-1080 | Activable Probe for Noninvasive Hydroxyl Radical Imaging, emitted in 1000-1400 nm after responding to ·OH |
|
| DCC2617 | Hydrocaffeoyl-fasudil 1d | Novel multitarget Fasudil derivative, inducing the NRF2 signature, promoting the expression of the antioxidant response enzymes HO-1 and NQO1, via a KEAP1-dependent mechanism |
|
| DCC2618 | Hydrolapachol | Novel potent and selective inhibitor of Schistosoma mansoni dihydroorotate dehydrogenase (SmDHODH) |
|
| DCC2619 | Hydroxyellipticine-1a | Novel selective r(CGG)exp probe, improving pre-mRNA splicing defects, inhibiting formation of nuclear inclusions and RANT in a FXTAS cellular model |
|
| DCC2620 | Hydroxymatairesinol | Natural antioxidant and anti-cancer agent, blocking the MAPK/NF-κB and activating Nrf2/HO-1 |
|
| DCC2621 | Hydroxytriolein | Novel anticancer agent, inhibiting lung cancer cell proliferation via a PKCa and ERK1/2 dependent mechanism |
|
| DCC2622 | Hymenidin | Natural antagonist of serotonergic receptors and inhibitor of CDK5/p25 and GSK-3ß |
|
| DCC2623 | Hys-32 | Novel analogue of combretastatin A-4, enhancing connexin43 expression |
|
| DCC2624 | Hz-ma Hybrid 11b | Novel potent and selective inhibitor of fat mass obesity-associated protein (FTO), being selectively over alkylation repair homologue 5 (ALKBH5), another DNA/RNA demethylase |
|
| DCC2625 | Iag-10 | Novel potent and selective inhibitor of human DNA polymerase kappa (hpol κ) |
|
| DCC2626 | Ianthellamide A | Selective kynurenine-3-hydroxylase inhibitor |
|
| DCC2627 | Ianthelliformisamine A Tfa Salt | Antibiotic enhancer against resistant Gram-negative bacteria |
|
| DCC2628 | Ianthelliformisamine B Tfa Salt | Antibiotic enhancer against resistant Gram-negative bacteria |
|
| DCC2629 | Ianthelliformisamine C Tfa Salt | Antibiotic enhancer against resistant Gram-negative bacteria |
|
| DCC2630 | Iap-in-1 | Novel antagonist of IAP (inhibitor of apoptosis protein) |
|
| DCC2631 | Iaxo-101 | Novel inhibitor of the cluster of differentiation 14 innate immunity pathway |
|
| DCC2632 | Ibe-667 | Novel activator of LFA-1-ICAM-1 binding |
|
| DCC2633 | Ibl-302 | First-in-class triple-acting PIM/PI3K/mTOR inhibitor, demonstrating single-agent, anti-tumour efficacy in suppression of pAKT, pmTOR and pBAD in the SKBR-3, BT-474 and HCC-1954 HER2+/PIK3CA-mutated cell lines |
|
| DCC2634 | Ibpr001 Hydrochloride | Novel Aurora kinase inhibitor |
|
